Stock Quotes: Ovid Therapeutics Inc (OVID)

Brandmark of ovidrx.com (OVID)

The success of Ovid Therapeutics Inc. (OVID) relies on clinical trial results for treatments of rare brain pathologies, while the company's liquidity stands at 2.40. The business is building a closed therapeutic ecosystem around unique enzyme inhibitors to combat epilepsy. This price chart, which clearly demonstrates changes, confirms a risk-mitigation strategy through the creation of innovative treatment methods for severe neurological disorders in children and adults.

OVID - Ovid Therapeutics Inc. Market Chart over the range 07/04/2022 - 11/17/2026

Ovid Therapeutics Inc. (OVID) - metric breakdowns and financial figures

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:Ovid Therapeutics Inc OVID
Signature product of Ovid Rx

The price reflects the aggregate market valuation of a single share, serving as an indicator of investor expectations regarding the business's future cash flows. By analyzing the price action of the securities, one can track how the market re-evaluates the binary risks of drug development at Ovid Therapeutics Inc. (OVID), considering the stabilizing effect of regular licensing royalties from strategic partners within the company's revenue structure.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|NMRA - Price Chart|SCLX: Price Chart|TVGN: Stock Price|Alpha Cognition (ACOG) - Stock Price|Stock Quotes CGTX|Stock Price Inhibikase Therapeutics|Stock Price SAVA|Market Chart Assertio Holdings|Stock Price COYA (Coya Therapeutics)|VTGN: Share Price|Acumen Pharmaceuticals - Stock Price|Price Performance Chart CRVO (CervoMed Inc.)|ATHE (alteritytherapeutics.com) - Stock Quotes|CLNN - Market Chart|Stock Quotes PEPG|Stock Price jupiterneurosciences.com|Price Chart Relmada Therapeutics (RLMD)|ANVS (Annovis Bio, Inc.) - Price Performance Chart|Stock Price GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel